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                            A 25－YEAR REVIEW
Juichi KAwAMuRA， Yoichi TANAKA， Yoshihito HiGAsHi， Yusaku OKADA，
       Tatushiro OKABE， Mieko MiyAKAwA and Osamu YosmDA
         Fr・m伽1）ePartment ・f Ur・1・島伽吻of Medic鵬・ゆ・彦・翫蜘吻
                          r1）irect・r：P彫0．｝「・sゐidaノ
    The 55 cases of transitional cell carcinorna of the renal pelvis seen at Kyoto University Hospital
between 1955 and 1979 were reviewed and factors predicting the prognosis were investigated． Patients
ranged in age from 37 to 86 years， with a mean of 64．2． There were 42 men and 13 women， or a
ratio of 3．2：1．O． Thirty－three tumers were found en the left side， 22 on the right side． According
to the modified Batata’s stage classification of the ureteral tumor， 7 cases were classified stage A， 11
cases stage B， 21 cases stage C and 16 cases stage D．
    1． Over－all relative survival rate at 1 year， 2 year， 3 year， 5 year， I O year were 90．90／．， 79．50／．，
65．10／．， 54．50／．， 52．IO／．， 44．70／o， respectively．
    21 Survival was more dependent on the stage than the grade ofthe tumor． There was no difference
between stage A and B in the estimated survival rate for a 1 e－year follow－up． Five and 10 year survival
rates were 71．40／． and ’71．40／， in the stage A， 76．7D／o and 57．50／o in the stage B， respectively． Although
a 2－year survival rate of stage’ C was superior to the overall survival rate， patients with stages C and
D had an ominous prognosis beyond a 3－year follow－up． Five and 10 year survival rates were ．31．90／，
and 19．70／． in the stage C， 15．30／． and 15．30／． in the stage D， respectively．
    3． There was a strong correlation between IVP findings and tumor stage． The prognosis’ of
patients presenting with a non－visualizing IVP is poor generally beyond a 2－year follow－up． Pre－
operative values of’erythrocyte sedimentation rate werg dependent ・on the stage of the tumor and es－
pecially， more than 50 mm of erythrocyte sedimentation rate （1 hour） indic’ates a poor prognosis．
    4． lpsilateral ureteral tumors were noticed simultaneously in 14 patients （25．50／．） who had high
grade and high stage tumors． Postoperatively， bladder tumors occurred in 17 patients （30．90／．）．
Most of tumors were f（）und within 2 years fbllowing the operation． In general，3一，4－and 5－ycar
survival rates were lower in patients with associated uroepithelial malignancies， however， this reflected
a’ peor prognosis of patients with simultaneous ureteral tumors． The occurrence of bladder tumors，
per se， did not affect the overall outcome．
    5． A cotnparisQn of the prognosis between two series of different operative modalities was made．
One series comprising． 30 patients was operated with nephrectomy with extirpation of varying length
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of the ureter． The other series comprising 25 patients had surgery of total nephroureterectomy with
cuff． The survival rate beyond a 2－year follow－up was higher in the latter than in the fQrmer． Re－
currence of the bladder tumor was found in 370／， in the former and 240／， in the latter but those figures
were not significant statistically．
  In conclusion， the following clinical features indicate a poor prognostic outcome of this tumor．
  i） Over 64－year－old of the patient’age at the initial presentation．
 ii） Non－visualized kidney on IVP．
 iii） More than 50 mm of 1 hour value of erythrocyte sedimentation rate．
 iv） Operative modality of nephrectomy with incomplete resection of the ureter．
  v） Pathologically high stage of the extirpated pelvic tumor．
 vi） Simultaneous association of the ureteral tumors．



























30－39 40－49 50一一59 60－69 70一一79 80－
        Age （Years）
















Sense of residua［ urine
工nguinol PGin
46（ 85．6 el． ）
4（ア．3％｝
2（ 3．7 Olo ）
 ［（ L8 ele ）
 ［（ 1．8 Olo ｝








Fig． 2． Stage classification according to modified Batata’s classification of ureteral tumor
Table 2． Correlation between grade and stage
一stGrade A     B     C     DNo． （Olo） No． （elo｝ N o． （e／o） No． （Ole｝Tota1
1 O jUOO）且   7（3i．8〕 4（18．2）














Total 7（i2．7｝ ［1（20．0） 2 i（582｝ i 6（29．1） 55“OO．O）
Batataら2）による尿管腫瘍の伸達度分類を若＝F改訂し







 以上分類に従うと，stage Aは7例，stage Bはll例，
stage Cは2正｛列， stage Dは16例となり， grade Iは
1例，grade IIは22例， grade IIIは26例， grade IV
は6例となった．これら伸達度と悪性度との間には
Table 2に示すようにほぼ平行した関係がみられた．























908 泌尿紀要27巻 8号 1981年
Table 3． Correlation between IVP findings and grade or stage
         No． ofIVP tindings        patients
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Table 4．Relationship between renal arteriographic
findings and grade or stage
Renal arteriographic




Table 5． Erythrocyte sedimentation rate （ESR）
     according to the stage of the pelvic
     tumor














grade II， IIIが多く，こと｝こhigh gradeということ
はなかったが，伸達度についてはhigh stageのものが
多い傾向が認められ，後にも先にも尿管にだけ腫瘍の
Stσqe A    8．5｝士5．47＊
Stage B 21．64117．89
Staqe C 3 L98±21．21
Stoqe D   53，79士24．8【＊














Table 6． Associated uroepithelial malignancies （percent out of 55 patients）
Tlme of discovery
of the rnultiple tumorsUreteral tumor＊ Bladder tumorTo量a1
Before the pelvic tumor
（“AntecedentU）
Simultaneously
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Table 7．
川村・ほか：腎孟腫瘍
Relationship between occurrence of the ureteral tumor
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Table 8．Occurrence rate of the bladder tumor























Duration between the surgery and the occurrence ot the bladder tumor：
A“erage 17．5 months
＊ Average 一Z11．，．e．．8 months in the potients operated with nephrectomy
oRly or ［ncomplete nephroureterectomy
＊＊ Average 一9．．S．5 months in the patlents operated with total
nephroureterectomy



















Table 9．Follow－up study （1 month・・一13 years 9
months： Average 39．7 months）
died ot tumor一一一一一一一一一一一一一一’一一一一 22
died ot unre［ated cause一一一一一一一 6
died of unknown cause・一一一一一一一一 i
olive一一一一一一一一一一一一一一一一一一一一…一一一一一一一一 22
10st follow－up・…一一一一一一一一一一一一 4
（ October 3 fi ． i980）
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Fig． 6． Estimated survival rate according to pathologic stage of renal pelvic tumor
         I”able．10． IVP findings vS． estimated survival Tate
工VP findlngs No．otpatients M．
Estimated ＄urviva［ rate （Olo）


















＊significant between groups （P〈O・05｝
        
Table 11． Erythrocyte sedimcntation rate（ESR）， l hr． vs． estimated
       survival rate
ES R， 1 h． r．
No．of
patients Tt，
Estimated surviva［ rate （Ole）
2Yrs， 5 Yr’刀D 4 Yrs． 5 Yr＄， IOYrs．
1：under i5 mm
五二【5－50mm




















    Table 12． The mode gf surgery vs． estimated survival rate
Mode ot Surgery No，ofpatients’@tt．’
Esti．rngted survivai rate （Olo）







52，6 45．． 1 4 1． 4 24．8
86．9＊ 66．8＊ 50．1＊ 50．1＊ 50．1＊
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Table 13． With or without associated uroepithelial tumors vs． estimated survival rate
No． of
patients
Estlmated survivai rate （“le）














89． 73，2 65．5 51．4 44．0 53．0
90．3 75．0 49．9＊ 57．9＊ 57．9＊ 51，0
85．7 6i．2＃ 30．6＃ 20．4＃ 20．4＃ 20．4＃
94，i 79．i 60．8 48．0 48．0 41．1
＊ signlficont between Groups I and皿 〔pくO．05｝
＃siqnificon† between Groups I－a （】nd 三一b （pくQ．05｝
Table 14． Patient’s age vs． relative survival rate
potiens ’s age paNt？bOnftsRelative survival rate （“／o｝







87，5 78．0 65．8 ，56．0 5i．9 47，8
                ＊ ．A A＊94，8 75．5 58．4 44．0                42．2 29．3＊


















































































































Table 15． Associated uroepithelial malignancies
Reference（yeqr｝Ureteral tumor Bladder tumor No． （el．｝． No． （el．｝
Totals
No， （Ole）
      22）Taylor （1959）
宕臨。卿（、967）・・
画題鼎67〕・5）
         i7）Say and Hor  （1974）
Rubenstein and
6＄’sVoVc’i d一 t’e－s’ ’ ’“ Vg’ 7Vs 1 8）
Kawamura and
assoc［ates （［ 98i）














＊ lncluding ontecedent bladder tumor
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year 5 year 5 year IO year









55 90，9 87，2 65．1 55．2 52．i 4 i，8
49 90．0 83．0 69．1 62，1 55．4 44．5
1965－1977 540 89．2 86，5 81．5 75，2 78．5 64．9
44．7 51，4
42，5 29．5
R＊： Relative survival rate
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